Cassava Sciences | PTIE - Loan Capital


Cassava Sciences reported $0 in Loan Capital for its fiscal quarter ending in December of 2024.





Loan Capital Change Date
Abbott USD 29.64B 19.74B Mar/2026
Amgen USD 51.86B 27M Jun/2026
Biogen USD 7.29B 1B Jun/2026
Cara Therapeutics USD 0 0 Mar/2025
Cassava Sciences USD 0 0 Dec/2024
Eisai JPY 184.6B 49.83B Jun/2026
Eli Lilly USD 47.86B 8.49B Jun/2026
Geron USD 120.13M 298K Jun/2026
J&J USD 37.34B 183M Jun/2026
Merck USD 51.08B 4.41B Jun/2026
Novartis USD 37.49B 42M Jun/2026
Novavax USD 246.3M 200K Dec/2025
Pfizer USD 60.5B 70M Jun/2026
Roche Holding CHF 25.22B 2.21B Jun/2026